Insilico Medicine, an end-to-end AI-powered drug discovery company, has announced the appointment of Dr. Michelle Chen to the company’s position of Chief Business Officer. In this role, Dr. Chen will oversee the company’s corporate strategies and business development activities. Dr. Chen brings more than 20 years of extensive experience in both biopharma and technology industries.…